# Iaso Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/iaso-therapeutics

- Industry: Biotechnology
- Headquarters: East Lansing, US
- Website: www.iasotherapeutics.com
- Total disclosed funding: $0.4M
- Latest round: Seed (Dec 22, 2022)
- Investors on record: 2

## About

Founded in 2018 by Xuefei Huang (CSO), and based in Michigan, US, Iaso Therapeutics, Inc. a spin-out of Michigan State University operates as a biotechnology company that develops therapeutics for cancer and infectious diseases treatment. In January 2023, Iaso Therapeutics, Inc. raised USD 1.25 million in seed funding from new investors Michigan Rise, Red Cedar Ventures, and individual investors. As of January 2023, the company is being led by its CEO, Robert Forgey. 

The company has created a proprietary mutant bacteriophage Q (mQ) platform technology that demonstrates a higher immune response in mQ to aid in the development of vaccines against a variety of diseases, including cancer and microbial infections.

## Funding rounds

- Seed, Dec 22, 2022, $0.4M — Red Cedar Ventures, Michigan Rise

## Investors

- Red Cedar Ventures (https://capitalatlas.ai/funds/red-cedar-ventures) — Seed
- Michigan Rise (https://capitalatlas.ai/funds/michigan-rise) — Seed